Malignant gliomas, particularly glioblastoma, represent one of the most formidable challenges in neuro-oncology due to their diffuse infiltration, molecular heterogeneity and robust mechanisms of ...

Please provide your email address to receive an email when new articles are posted on . Men were significantly younger and underwent surgery faster after diagnosis compared with women. No sex-related ...

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have pinpointed a combination immunotherapy treatment that enhances the immune response for people with malignant gliomas, an ...

Approximately 18,500 persons are diagnosed with malignant glioma in the United States annually. Few studies have investigated the comprehensive economic costs. We reviewed the literature to examine ...

Safety and efficacy of the addition of bevacizumab to temozolomide and radiation therapy followed by bevacizumab, temozolomide, and irinotecan for newly diagnosed glioblastoma multiforme. This is an ...

Malignant gliomas are among the deadliest brain cancers, with limited treatment options and poor survival. A new comprehensive review analyzes decades of global clinical data on boron neutron capture ...

Exousia Pro Inc.’s subsidiary, Exousia AI, has received orphan drug designation from the FDA for its exosome-based treatment for malignant glioma.

Glioblastoma, the most aggressive primary brain tumor, is characterized by infiltrative growth, resistance to therapy, and a dismal prognosis, with median survival rarely exceeding 16 months ...

HOUSTON, Texas (KTRK) -- Six months ago, we told you about a young woman who was diagnosed with a deadly brain tumor only found in children. She has been on a journey with Houston Methodist Hospital ...